October Pharma Co. (OCPH) Key Statistics
26 reported figures for October Pharma Co. — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 4.33B
- P/E (trailing)
- 49.08
- P/B
- 5.41
- Dividend yield (FY 2020)
- 0.42%
Income (latest fiscal year)
- Revenue
- EGP 544.13M
- Net income
- EGP 88.26M
- EBITDA
- EGP 163.69M
- Free cash flow
- EGP 15.74M
- Profit margin
- 16.22%
Balance sheet
- Total assets
- EGP 606.15M
- Total debt
- EGP 271.65M
- Book value
- EGP 800.05M
Growth
- Revenue growth
- 3.9%
- Profit growth
- 160.89%
- EPS growth
- 160.9%
Per share
- EPS (fiscal year)
- 3.68
- Book value per share
- 33.34
- Dividend per share
- 0.75
- Return on equity
- 40.64%
- Return on assets
- 15.32%
Technical
- RSI (14)
- 39.4
- 50-day moving average
- EGP 227.35
- 200-day moving average
- EGP 170.52
- Beta (1Y)
- 0.91
Shares
- Shares outstanding
- 24M
- Free float
- 11.73%
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.